Bloodletting: From Ancient Cure to Modern Therapy
Explore the evolution of bloodletting, leeches, and phlebotomy—from millennia-old humoral theories to targeted 21st-century applications.

Bloodletting, the deliberate removal of blood for therapeutic purposes, has shaped medical practice for over 3,000 years, transitioning from a catch-all treatment rooted in ancient humoral theory to selective modern applications like therapeutic phlebotomy and medicinal leech use.
Origins in Ancient Civilizations
The practice emerged among ancient Egyptians around 3000 years ago, who viewed blood removal as a way to expel impure fluids and restore bodily equilibrium. This belief spread to Greek physicians like Hippocrates in the 5th century BC, who recommended it for fevers, inflammation, and apoplexy, seeing it as a method to balance vital forces.
Romans adopted and expanded these ideas, with writers like Celsus in the 1st century AD proclaiming bloodletting useful for nearly every ailment, marking it as a staple in early Western medicine. Erasistratus theorized diseases stemmed from blood plethora, advocating depletion through bleeding alongside diet and exercise, while his student Herophilus endorsed venesection directly.
Humoral Theory and Its Lasting Grip
Central to bloodletting’s endurance was the humoral theory, positing four bodily fluids—blood, phlegm, yellow bile, and black bile—whose imbalance caused illness. Excess blood, deemed the primary humor by Galen of Pergamum (129–200 AD), necessitated removal to prevent disease.
This framework dominated from antiquity through the Middle Ages and Renaissance. Galen’s influence peaked in Europe during the 19th century, despite anatomical discoveries by Vesalius and Harvey challenging it. Social, economic, and intellectual factors sustained the practice, as physicians relied on visible blood loss to signal intervention.
Tools and Techniques of Historical Bloodletting
- Venesection: Direct vein incision using lancets or fleams—foldable, multi-bladed tools akin to pocketknives—for general blood removal, often until patient syncope after about 600mL.
- Scarification and Cupping: Skin scraping with brass devices containing tiny knives, followed by heated glass cups to draw blood locally.
- Leech Therapy: Medicinal leeches (Hirudo medicinalis) ingested 5–10mL of blood per feeding, favored for precise, localized depletion over inflamed organs.
Barber-surgeons performed these, leading to the red-and-white barber pole symbolizing blood and bandages. Prophylactic use extended to healthy individuals for vigor.
Peak Popularity and Notable Cases
Bloodletting reached zenith in 18th-19th century Europe, promoted by François Broussais (1772–1838), who attributed fevers to organ inflammation and prescribed aggressive leeching—up to 50 at once—alongside venesection.
King Charles II’s 1685 death exemplified excesses: post-seizure, he endured 24 ounces of blood via arm, cupping, and jugular veins, plus emetics and purgatives. During the American Civil War, overwhelmed medics bled patients amid disease outbreaks.
| Historical Figure | Treatment Details | Outcome |
|---|---|---|
| Charles II (1685) | 24 oz blood, emetics, jugular bleeding | Death after seizures |
| Francois Broussais’ Patients | Leeches on inflamed organs, aggressive phlebotomy | Widespread use for fevers |
Scientific Challenge and Decline
William Harvey’s 1628 circulation discovery undermined humoralism, yet bloodletting persisted. 18th-century skeptics like René Laennec questioned it, and Pierre Charles Alexandre Louis’s 1830s numerical method proved ineffectiveness for pneumonia.
Edinburgh debates in the 1840s–1850s between Alison and Bennett highlighted divides, with practice varying by physician belief. By late 19th century, evidence discredited it for most ills, confining it to niches.
Revival Through Therapeutic Phlebotomy
Today, phlebotomy treats polycythemia vera (excess red cells causing clots), hemochromatosis (iron overload), and porphyria. It reduces blood viscosity, lowers iron, and manages hyperviscosity syndromes.
- Polycythemia Vera: Regular 500mL draws maintain hematocrit below 45%.
- Hemochromatosis: Weekly phlebotomy depletes iron stores.
- Non-Specific Uses: Heart failure, hypertension in select cases.
Guidelines from bodies like the American Society of Hematology standardize volumes based on hemoglobin.
Medicinal Leeches in Contemporary Surgery
Hirudo medicinalis aids microsurgery, especially reattachments. Leech saliva’s hirudin anticoagulates, preventing venous congestion; histamine and hyaluronidase aid flow; bdellins fight bacteria.
FDA-approved since 2004 for such uses, leeches salvage 80% of congested flaps. Post-detach, they draw blood for 20–60 minutes, yielding clear exudate. Risks like infection are managed with antibiotics.
Comparing Historical vs. Modern Practices
| Aspect | Historical Bloodletting | Modern Phlebotomy/Leeches |
|---|---|---|
| Basis | Humoral imbalance | Specific pathologies (e.g., polycythemia) |
| Tools | Lancets, fleams, leeches | Sterile needles, FDA-approved leeches |
| Indications | Fevers, inflammation, nearly all ills | Hemochromatosis, reattachment surgery |
| Risks | Syncope, anemia, death | Controlled, monitored |
Ethical and Regulatory Considerations
Modern use demands informed consent, sterile protocols, and oversight. Leech farms ensure disease-free supply; disposal follows biohazard rules. Therapeutic phlebotomy occurs in clinics with hemoglobin tracking.
FAQs
What conditions require therapeutic phlebotomy today?
Primarily polycythemia vera, hemochromatosis, and secondary erythrocytosis to normalize blood parameters.
Are medicinal leeches safe in surgery?
Yes, when sourced from controlled facilities; antibiotics prevent rare Aeromonas infections.
Why did bloodletting decline?
Scientific studies like Louis’s in the 1830s demonstrated no benefit for common diseases, shifting paradigms.
Can anyone receive phlebotomy?
No, only under medical supervision for diagnosed conditions; healthy individuals risk harm.
How much blood is removed in modern sessions?
Typically 450–500mL, adjusted for weight and hemoglobin levels.
Future Directions
Research explores automated phlebotomy devices and leech-derived anticoagulants for drug development, potentially expanding targeted therapies while honoring history’s lessons.
References
- The history of bloodletting — BCMJ. 2019-01-01. https://bcmj.org/premise/history-bloodletting
- A Brief History of Bloodletting — Journal of Lancaster General Hospital. 2019-12-01. https://www.jlgh.org/Past-Issues/Volume-11-Issue-4/Brief-History-of-Bloodletting.aspx
- Bloodletting — Wikipedia (references primary historical texts). 2026-01-01. https://en.wikipedia.org/wiki/Bloodletting
- What to Know About the History of Bloodletting — WebMD. 2023-05-15. https://www.webmd.com/a-to-z-guides/what-to-know-history-bloodletting
- The Long, Respected History of Bloodletting — Duke Today. 2000-02-18. https://today.duke.edu/2000/02/blood218.html
Read full bio of medha deb








